Purpose: The stability of oxaliplatin in infusion bags containing 5% dextrose injection was studied.
Methods: Solutions of oxaliplatin 0.7 mg/mL were prepared in polyolefin infusion bags containing 5% dextrose injection and stored at 3-7 degrees C in a lightproof bag, at 20-24 degrees C with continuous exposure to artificial light, and at 20-24 degrees C with continuous exposure to fluorescent light in a lightproof bag. Samples were analyzed at 1, 2, 3, 4, 5, 7, 14, and 30 days and assayed in duplicate. Stability was measured using a stability-indicating high-performance liquid chromatographic method. Samples were also examined for changes in color and pH and for the presence of particulate matter.
Results: All samples retained over 90% of their initial concentration over the study period. No color changes or visible precipitation was observed, and the pH of all samples remained stable. Neither temperature nor artificial light had any significant effect on the stability of oxaliplatin.
Conclusion: Oxaliplatin 0.7 mg/mL in infusion bags containing 5% dextrose injection was chemically stable for at least 30 days at both 3-7 degrees C and 20-24 degrees C without regard to light exposure.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.2146/ajhp060369 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Conventional versus task-based package organization for out-of-hospital emergency kits: an emergency medical services simulation study.
Scand J Trauma Resusc Emerg Med
December 2024
Medical University of Vienna, Department of Anaesthesia, Intensive Care Medicine and Pain Medicine, Division of General Anaesthesia and Intensive Care Medicine, Spitalgasse 23, 1090, Vienna, Austria.
Background: Emergency Medical Service crews are equipped with comprehensive emergency kits for routine care and to provide life-saving interventions in severely ill patients. While guidelines on contents and packing strategies of emergency kits for specific tasks and specialized situations exist, data for the design of out-of-hospital emergency kits in a general urban population is lacking. It may be possible to transfer the promising results of modern in-hospital packing strategies such as task-based package organization (TPO) to an Emergency Medical Service setting.
View Article and Find Full Text PDFPhysicochemical Stability of Nab-Paclitaxel (Pazenir) Infusion Dispersions in Original Glass Vials and EVA Infusion Bags.
Pharmaceutics
October 2024
Department of Pharmacy, University Medical Centre of Johannes Gutenberg-University, Langenbeckstraße 1, 55131 Mainz, Germany.
Background/objectives: The study objective was to determine the physicochemical stability of nab-paclitaxel (Pazenir) ready-to-use (RTU) dispersion for infusion in original glass vials and ready-to-administer (RTA) infusion dispersion in EVA infusion bags.
Methods: Triplicate test dispersions were prepared and stored light protected for a maximum of 28 days either in the original glass vials (RTU) at 2-8 °C or in EVA infusion bags (RTA) at 2-8 °C and at 25 °C. Directly after reconstitution and on days 1, 3, 5, 7, 14, 21, and 28 samples were withdrawn and paclitaxel concentrations assayed by a stability-indicating HPLC method.
An Assessment of Surface Contamination and Dermal Exposure to 5-Fluorouracil in Healthcare Settings by UPLC-MS/MS Using a New Atmospheric Pressure Ionization Source.
Toxics
October 2024
Centre for Environment and Health, Department of Public Health and Primary Care, University of Leuven (KU Leuven), 3000 Leuven, Belgium.
5-Fluorouracil (5-FU) is a well-known cytostatic drug, which is often used in cancer treatments. Yet, it is also a very dangerous compound for people who are occupationally exposed to it for a long time, such as pharmacy employees, nurses and cleaning staff. We aimed to improve and implement a LC-MS/MS method for 5-FU quantification on surface contamination samples collected with swabs in a pharmacy department and outpatient nursing station of a university hospital.
View Article and Find Full Text PDFIn-Use Physicochemical Stability of Sandoz Rituximab Biosimilar in 0.9% Sodium Chloride Solution After Prolonged Storage at Room Temperature Conditions.
Drugs R D
December 2024
Medical Oncology, Sandoz GmbH, Holzkirchen, Germany.
Article Synopsis
- This study examined the stability of Sandoz rituximab biosimilar (SDZ-RTX) under various storage conditions, focusing on both in-use and out-of-fridge scenarios to ensure patient safety.
- The researchers subjected two SDZ-RTX batches to long-term refrigeration followed by exposure to higher temperatures and humidity to simulate real-world storage situations.
- Results indicated that SDZ-RTX maintained its physicochemical and biological quality, meeting strict acceptance criteria even after exposure to elevated temperatures, provided it was prepared in a sterile environment.
Appropriateness of intravenous fluid prescriptions in hospitalised patients: a point prevalence study.
Int J Clin Pharm
February 2025
Department of Pharmacy, CHU-UCL Namur, Av. Gaston Therasse 1, 5530, Yvoir, Belgium.
Background: Inappropriate use of intravenous (IV) fluids results in fluid overload, electrolyte disturbances, and increased costs.
Aim: To describe IV fluid prescribing and its appropriateness in hospitalised patients.
Method: A point prevalence study was conducted at two sites (academic and general) of a tertiary care hospital in Belgium.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!